Clinical Trial Update: Effect of Exendin-(9-39) on Glycemic Control in Subjects With Congenital Hyperinsulinism [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on the effect of Exendin-(9-39) on glycemic control in congenital hyperinsulinism. The study includes Phase 1 and Phase 2 cohorts with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Hyperinsulinism

Drugs mentioned

• Exendin 9-39 (exendin-9-39)

Snippet

Sponsor: Diva De Leon | Conditions: Congenital Hyperinsulinism | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-11-09